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In the treatment of neoplastic di-
seases, the therapeutic use of folate
antagonists such as methotrexate is often
accompanied by the concurrent or subse-
quent administration of 5-formyltetra-
hydrofolate (folinic acid, leucovorin) in
order to reverse its effects (Mead et al.,
1963; Hryniuk and Bertino, 1969).
In vitro, this reduced folate is readily
altered by acid conditions (May et al.,
1951) such as may exist in the stomach,
and it has, therefore, been administered
parenterally. It has been recognized for
some time (Nixon and Bertino, 1972) that
an effective, orally administered, reduced
folate would have a useful place in the
increasing use of cancer chemotherapy,
and effective absorption of oral doses up
to 1 mg has been demonstrated (Chanarin,
1969; Nixon and Bertino, 1972). Such
doses are small compared to those em-
ployed therapeutically (often greater than
20 mg) and further evidence of acceptable
absorption in this dose range would be
desirable.
Each of three pairs of healthy Cau-
casian male volunteers (Table) were ran-
TABLE.-Characteristics of Volunteers
Characteristic
Age
Height
Weight
Surface area
Range
21-29 yrs
173-190 cm
63-77 kg
1-72-1-91 m2
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domly allocated either an oral or an
intramuscular (i.m.) dose of 21 mg of
5-formyltetrahydrofolate. The subjects
were taking normal diets and were not
receiving any form of medication.
Serum samples were taken for folinic
acid estimation before administration of
the drug and after 15, 45, 120, 240 and
360 min.
Folinic acid concentrations were esti-
mated using the growth response of
Lactobacillus casei, which responds to most
folic acid derivatives, including folinic
acid and 5-methyltetrahydrofolate. Much
of the folinic acid will be converted to the
5-methyl form by the intestinal mucosa
(Whitehead, et. al. 1972). The procedure
adopted was amodification ofthatemploy-
ed by Herbert (1961) and used in the
routine haematology laboratory for the
measurement of serum folate. In this ex-
periment, except for the initial samples,
serum was diluted x 100, usingphosphate
buffer with 1% ascorbic acid, to bring
the results within the reliable range of
the assay procedure.
All subjects had normal serum folate
levels at the start of the experiment.
The mean folinic acid concentrations
found in each group of subjects are shown
in the Fig. together with the range of
results at each point. Although the peak
concentration reached after oral adminis-
tration was delayed by 75 min compared
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FIG. Mean and range of serum folate levels after 21 mg folinic acid orally 0 0 and i.m. 0 0.
to thatfollowing i.m. injection, subsequent
concentrations were higher in the oral
group.
Assuming a similar rate of blood
clearance ofthe drug (via the kidneys and
into the body stores), the area under each
curve will be related to the total quantity
of folinic acid absorbed. The area under
the i.m. curve is 2485 units; that under
the oral curve is 2328 units. Thedifference
between these two areas is 6-3%, and
inspection ofthe graph suggests that ifthe
time period of measurement had been
extended the difference would have been
smaller.
It is possible that high doses of metho-
trexate may impair the absorption of
folinic acid by the intestinal mucosa. We
have found that the bioassay system
employed to measure serum folate does
not produce reliable results, using serum
from patients who have received a high
dose of methotrexate (200 mg by i.v.
infusion over 24 h). However, Whitehead
et al. (1972) have shown that, after 2 mg
of oral folinic acid, a proportion is
absorbed directly into the blood without
metabolism by the intestinal mucosa.
Any blockage of folinic acid metabolism
at that site may thus be bypassed by a
much more extensive direct absorption
from a large dose.
Hoffbrand and Fry (1972), using the
urinary excretion test, measured the
absorption of orally administered tritium-
labelled folic acid in patients who had or
had not received 25 mg of methotrexate.
They found that the methotrexate did not
seem to affect the quantity of folate
absorbed. This underlines a clinical
impression in several centres that patients
who have been given oral folinic acid
empirically after methotrexate therapy
have fared as well as when receiving it
parenterally.
In these circumstances, the relatively
small differences between the blood levels
reached after oral and i.m. administration,
which we have demonstrated above,
suggest that satisfactory absorption of
folinic acid occurs after large, oral doses
and that it may, therefore, be possible to
avoid the parenteral route.
We would like to thank Professor
R. E. M. Thompson, Professor J. Stewart
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